11.BETA.,17-DIHYDROXY-3,20-DIONE-1,4-PREGNADIENE-21-YL-2'-ACETAMIDO-2'-DEOXY-.BETA.-D-GLUCOPYRANOSIDE
UNII 67K3TA7HI9
Substance Identification & Data
This profile provides standardized clinical and technical data for 11.beta.,17-dihydroxy-3,20-dione-1,4-pregnadiene-21-yl-2'-acetamido-2'-deoxy-.beta.-d-glucopyranoside, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 67K3TA7HI9.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 26884-47-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C29H41NO10 YQELRSRKLBGIGK-PTJHMBADSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 11.beta.,17-dihydroxy-3,20-dione-1,4-pregnadiene-21-yl-2'-acetamido-2'-deoxy-.beta.-d-glucopyranoside. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.